in this issue
Markets :: Fine Chemicals/Biotech :: Industrial Biotech
Excelsyn Mulls Technology Backlog Spin-Off
9:59 AM MST | March 3, 2008 | Alex Scott
Excelsyn (Holywell, U.K.), a custom synthesis firm, may spin off a backlog of six fields of intellectual property (IP) into a separate company, CW has learned. The IP relates to four distinct areas of biotransformation technology and two organometallic catalyst technologies. Shott: May approach venture capital firms. Excelsyn does not currently have access to enough capital to fully exploit the technology backlog and a spin-off appears to be the best course of action, Excelsyn managing director and founder Ian Shott says. Excelsyn will consider options during the...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee